US FDA issues import alert on Sun Pharma's Halol facility

Sun Pharma on Thursday said the US Food and Drug Administration (USFDA) has imposed an import alert on its Halol manufacturing site in Gujarat, that bans future shipments of products from the facility to the US market, until resolution of regulatory compliance issues flagged by the regulatory agency.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PvijfzM
via IFTTT